Follow the Lead

Autor: Nada Al-Sakini, Jonathan R. Clague, Wei Li, Louit Thakuria, Thomas Semple, Sarah Ghonim, Wasyla Ibrahim, Michael A. Gatzoulis, Samuel Seitler, Andreas Hoschtitzky

Publikováno v: JACC Case Reports

We present the challenging case of a young man with congenital heart disease who survived severe device-related infective endocarditis and new pulmonary hypertension. He required prolonged mechanical circulatory support and had multiple significant c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cfa433de89e3b8119b3e299cf2f42e4
https://doi.org/10.1016/j.jaccas.2021.05.012

The long-term outcomes of cardiac implantable electronic devices implanted via the femoral route

Autor: Samuel Griffiths, Jonathan M. Behar, Daniel B. Kramer, Mike T. Debney, Christopher Monkhouse, Alicia Y. Lefas, Martin Lowe, Fouad Amin, Emily Cantor, Vennela Boyalla, Nabeela Karim, Jan Till, Vias Markides, Jonathan R. Clague, Tom Wong

Publikováno v: Pacing and clinical electrophysiology : PACE. 45(4)

BACKGROUND: Conventional superior access for cardiac implantable electronic devices (CIEDs) is not always possible and femoral CIEDs (F-CIED) are an alternative option when leadless systems are not suitable. The long-term outcomes and extraction expe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13397a929b019a531551641112465861
https://pubmed.ncbi.nlm.nih.gov/35043404

Pacing in congenital heart disease – A four-decade experience in a single tertiary centre

Autor: Tom Wong, Karen Lascelles, Disha Midha, K Dimopoulos, Julian W.E. Jarman, Jonathan R. Clague, Zhong Chen, Howell J. Williams, Sonya V. Babu-Narayan, David G. Jones, Michael A. Gatzoulis, Vias Markides, Janice A. Till

Publikováno v: International Journal of Cardiology. 241:177-181

Background The increased risk of brady- and tachy-arrhythmias in the congenital heart disease (CHD) population means that cardiac rhythm management devices are often required at an early age and expose patients to device-related complications. The pr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::550c9ef2bf4d821a92ff4b8bf5a1e384
https://doi.org/10.1016/j.ijcard.2017.02.151

Outcomes and costs of left atrial appendage closure from randomized controlled trial and real-world experience relative to oral anticoagulation

Autor: Sandeep Panikker, Lilian Mantziari, Tom Wong, Jonathan R. Clague, Edward D. Nicol, S. Armstrong, Vias Markides, Wajid Hussain, Julian W.E. Jarman, David G. Jones, John P. Foran, Habib Khan, Shouvik Haldar, Charles Butcher, Joanne Lord

Publikováno v: European Heart Journal. 37:3470-3482

Aims The aim of this study was to analyse randomized controlled study and real-world outcomes of patients with non-valvular atrial fibrillation (NVAF) undergoing left atrial appendage closure (LAAC) with the Watchman device and to compare costs with

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe9508614c7aa70acde61c601a8e0288
https://doi.org/10.1093/eurheartj/ehw048

Catheter Ablation versus Thoracoscopic Surgical Ablation in Long Standing Persistent Atrial Fibrillation (CASA-AF): study protocol for a randomised controlled trial

Autor: Habib Khan, Wajid Hussain, Caroline Murphy, Ines Kralj-Hans, Darrel P. Francis, Julian W.E. Jarman, Jonathan R. Clague, Shouvik Haldar, David G. Jones, Neeraj Mediratta, Dhiraj Gupta, Simon Jones, Vias Markides, Tom Wong, Joanne Lord, Toufan Bahrami, Tushar V. Salukhe, Raad Mohiaddin, Joanna Kelly, Anthony De Souza

Publikováno v: Khan, H R, Kralj-Hans, I, Haldar, S, Bahrami, T, Clague, J, De Souza, A, Francis, D, Hussain, W, Jarman, J, Jones, D G, Mediratta, N, Mohiaddin, R, Salukhe, T, Jones, S, Lord, J, Murphy, C, Kelly, J, Markides, V, Gupta, D & Wong, T 2018, ' Catheter Ablation versus Thoracoscopic Surgical Ablation in Long Standing Persistent Atrial Fibrillation (CASA-AF) : Study protocol for a randomised controlled trial ', Trials, vol. 19, no. 1, 117 . https://doi.org/10.1186/s13063-018-2487-9
Trials, Vol 19, Iss 1, Pp 1-12 (2018)
Trials

Background Atrial fibrillation is the commonest arrhythmia which raises the risk of heart failure, thromboembolic stroke, morbidity and death. Pharmacological treatments of this condition are focused on heart rate control, rhythm control and reductio

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ce1faf230095685965efd1b0281ce3f
https://doi.org/10.1186/s13063-018-2487-9